News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,527 Results
Type
Article (5003)
Company Profile (17)
Press Release (219507)
Section
Business (82194)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3674)
Job Trends (3900)
News (120093)
Policy (7498)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Adcomms (3)
Allergies (9)
Alliances (14759)
ALS (18)
Alzheimer's disease (241)
Antibody-drug conjugate (ADC) (10)
Approvals (3687)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (45)
Cancer (416)
Cardiovascular disease (19)
Career advice (391)
Career pathing (2)
CAR-T (29)
Cell therapy (100)
Cervical cancer (2)
Clinical research (15983)
Collaboration (158)
Compensation (144)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (88)
Cystic fibrosis (16)
Data (473)
Depression (5)
Diabetes (37)
Diagnostics (2033)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40662)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37616)
Executive appointments (276)
FDA (3901)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (173)
Gene editing (15)
Generative AI (2)
Gene therapy (43)
GLP-1 (103)
Government (407)
Guidances (16)
Healthcare (5033)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (13)
Indications (6)
Infectious disease (316)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7814)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (4)
Legal (2330)
Liver cancer (17)
Lung cancer (49)
Lymphoma (25)
Management (10)
Manufacturing (45)
MASH (26)
Medical device (3852)
Medtech (3853)
Mergers & acquisitions (7416)
Metabolic disorders (111)
Multiple sclerosis (7)
NASH (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (1)
Neuroscience (324)
NextGen: Class of 2025 (1673)
Non-profit (727)
Northern California (850)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (20)
Partnered (4)
Patents (21)
Patient recruitment (26)
Peanut (5)
People (24493)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4765)
Phase II (6939)
Phase III (5531)
Pipeline (476)
Policy (4)
Postmarket research (625)
Preclinical (1860)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (63)
Real estate (1872)
Recruiting (8)
Regulatory (5088)
Reports (14)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (2)
Schizophrenia (19)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (654)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
United States (6550)
Vaccines (33)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Last 7 days (185)
Last 30 days (792)
Last 365 days (10236)
2025 (2349)
2024 (11027)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (183)
Alabama (13)
Alaska (2)
Arizona (58)
Arkansas (1)
Asia (11423)
Australia (1598)
California (1785)
Canada (659)
China (65)
Colorado (76)
Connecticut (90)
Delaware (27)
Europe (24397)
Florida (248)
Georgia (32)
Idaho (23)
Illinois (108)
India (5)
Indiana (59)
Iowa (1)
Japan (63)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (38)
Maryland (214)
Massachusetts (1435)
Michigan (84)
Minnesota (133)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (525)
New Mexico (5)
New York (445)
North Carolina (311)
North Dakota (2)
Northern California (850)
Ohio (53)
Oklahoma (5)
Oregon (3)
Pennsylvania (326)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (654)
Tennessee (34)
Texas (211)
Utah (57)
Virginia (39)
Washington D.C. (8)
Washington State (156)
West Virginia (2)
Wisconsin (19)
224,527 Results for "trethera corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trethera and UCLA Publish Data Demonstrating TRE-515 Ability to Control Immune Cell Activation That Causes Multiple Sclerosis Symptoms in Mice
February 26, 2025
·
5 min read
Press Releases
Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress
January 16, 2025
·
6 min read
Business
Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting
October 15, 2024
·
4 min read
Business
Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Advisory Board
Trethera Corporation announced the appointment of Michael Levy, MD, PhD, to its Scientific Advisory Board.
September 5, 2023
·
5 min read
Press Releases
Trethera Receives $2M NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
July 16, 2024
·
6 min read
Biotech Beach
Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
Trethera Corporation announced that it was awarded a $0.6M Small Business Technology Transfer grant from the National Institute for Allergy and Infectious Diseases.
June 27, 2023
·
6 min read
Business
Trethera Announces Appointment of Laurent Dubois to Board of Directors
Trethera Corporation, a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced the appointment of Laurent Dubois to the Trethera Board of Directors as an independent director.
February 15, 2023
·
4 min read
Drug Development
Trethera Receives NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a $600,000 Small Business Technology Transfer (STTR) grant from the National Institute of Allergy and Infectious Diseases (NIAID).
August 14, 2023
·
6 min read
Biotech Beach
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a Small Business Technology Transfer (STTR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) division of the National Institute of Health (NIH).
September 25, 2023
·
5 min read
Business
Trethera Announces Appointment of R. Boyd Quinnell to Board of Directors
Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Boyd Quinnell, CPA, MBA, to the Trethera Board of Directors as an independent director.
January 18, 2023
·
4 min read
1 of 22,453
Next
